Study co-authors include Joseph Kim, PhD, Bart Molemans, MD, Elizabeth Ireland (Amgen Ltd, in Uxbridge, United Kingdom); Florian Kronenberg, MD (Innsbruck Medical University, Austria); Pedro Aljama, MD (Hospital Reina Sofia de Cordoba, Spain); Stefan Anker, MD, PhD (Charit?©, Campus Virchow-Klinikum, in Berlin, Germany and IRCCS San Raffaele, in Rome, Italy); Bernard Canaud, MD (H pital Lapeyronie, in Montpellier, France); Peter Stenvinkel, MD, PhD (Karolinska Institute, in Stockholm, Sweden); Guntram Schernthaner, MD (Rudolfstiftung Hospital, in Vienna, Austria); Bruno Fouqueray, MD, PhD (Amgen (Europe) GmbH, in Zug, Switzerland); and Iain Macdougall, MD (King's College Hospital, in London, United Kingdom).

The article, entitled "Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients," will appear online at jasn.asnjournals/ on August 26, 2010, doi 10.1681/ASN.2009101017.

Source: American Society of Nephrology (ASN)